NEUP

AS OF

Dec 24 closing price

Price

$3.79

Change

+$0.02 (+0.53%)

Capitalization

20.38M

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

NEUP

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Neuphoria Therapeutics (NEUP) Ownership - Who owns Neuphoria Therapeutics?

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

NEUP

Capitalization

20.4M

P/E Ratio

0.78

Risk (Beta)

0.37

Dividend Yield

N/A

Total Cash

13.6M

Total Cash/Share

2.54

Total Debt

118K

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

8.42%

Revenue

15.6M

ROE

N/A

Book Value

12.5M

P/B Ratio

1.63

Cash Flow

N/A

Earnings

-4.02

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

Current Ratio

2.72

Current Revenue Per Employee

625000.00

Dividends Per Share - Security

N/A

EBITDA

-2.25M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-37.69

Shares Held By Institutions

2.12M

Shares Outstanding - Current

5.38M

Total Liabilities

14.8M

Total Volume MTD

N/A

Value

Gain YTD

10.496

View a ticker or compare two or three

Compare

NEUP

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for NEUP

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details